The treatment strategy for HF patients with SCH is intractable given the misconception that SCH is only a simple negative feedback regulation in heart disease and the lack of clinical research on thyroid hormone replacement therapy for HF patients with SCH. This evidence concerns the gene TG and hydrops fetalis.